LXU Healthcare to distribute Response Biomedical's heart tests in US states:
This article was originally published in Clinica
Vancouver, Canada-based diagnostics developer Response Biomedical has appointed LXU Healthcare, a medical equipment and specialty devices provider based in West Boylston, Massachusetts, as exclusive distributor of three of its RAMP cardiovascular tests in 19 US states. The assays, analysed by Response's fluorescence-based RAMP reader, detect the presence of troponin I, CK-MB and myoglobin, which enable the rapid diagnosis of various cardiovascular conditions. The agreement also covers the future distribution by LXU of Response's new NT-proBNP test, which is expected to be available at the end of 2006.